Northwest Biotherapeutics (NWBO) Assets (2016 - 2025)
Historic Assets for Northwest Biotherapeutics (NWBO) over the last 17 years, with Q3 2025 value amounting to $30.6 million.
- Northwest Biotherapeutics' Assets rose 439.28% to $30.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.6 million, marking a year-over-year increase of 439.28%. This contributed to the annual value of $26.7 million for FY2024, which is 408.04% down from last year.
- Per Northwest Biotherapeutics' latest filing, its Assets stood at $30.6 million for Q3 2025, which was up 439.28% from $29.5 million recorded in Q2 2025.
- In the past 5 years, Northwest Biotherapeutics' Assets ranged from a high of $40.2 million in Q4 2021 and a low of $26.7 million during Q4 2024
- Moreover, its 5-year median value for Assets was $29.3 million (2024), whereas its average is $30.1 million.
- In the last 5 years, Northwest Biotherapeutics' Assets surged by 25347.93% in 2021 and then crashed by 2200.45% in 2022.
- Quarter analysis of 5 years shows Northwest Biotherapeutics' Assets stood at $40.2 million in 2021, then decreased by 22.0% to $31.3 million in 2022, then dropped by 11.04% to $27.9 million in 2023, then decreased by 4.08% to $26.7 million in 2024, then increased by 14.52% to $30.6 million in 2025.
- Its last three reported values are $30.6 million in Q3 2025, $29.5 million for Q2 2025, and $27.5 million during Q1 2025.